Dublin, May 01, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/zfzpgv/huntingtons) has announced the addition of the "Huntington's Disease Therapeutics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Huntington's Disease Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World.
Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a five-year historic analysis is provided for these markets.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 25 companies including many key and niche players such as:
- Alnylam Pharmaceuticals, Inc.
- Auspex Pharmaceuticals, Inc.
- Intellect Neurosciences Incorporation
- Lundbeck A/S
- Prana Biotechnology Limited
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. HD THERAPEUTICS MARKET TRENDS
3. HUNTINGTON'S DISEASE PIPELINE ANALYSIS
4. RESEARCH BREAKTHROUGHS IN HD ARENA
5. AN OVERVIEW OF HUNTINGTON'S DISEASE
6. RECENT INDUSTRY ACTIVITY
7. FOCUS ON SELECT PLAYERS
8. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 25
- The United States (13)
- Canada (1)
- Europe (8)
- - France (1)
- - Germany (1)
- - The United Kingdom (2)
- - Italy (1)
- - Rest of Europe (3)
- Asia-Pacific (Excluding Japan) (3)
For more information visit http://www.researchandmarkets.com/research/zfzpgv/huntingtons